[HTML][HTML] Invasive lobular carcinoma of the breast: the increasing importance of this special subtype

AE McCart Reed, L Kalinowski, PT Simpson… - Breast Cancer …, 2021 - Springer
Invasive lobular carcinoma (ILC) is the most common of the breast cancer special types,
accounting for up to 15% of all breast cancer cases. ILCs are noted for their lack of E …

[HTML][HTML] Lobular carcinoma in situ: diagnostic criteria and molecular correlates

A Sokolova, SR Lakhani - Modern Pathology, 2021 - Elsevier
Lobular neoplasia (LN) is an atypical proliferation of small, dyscohesive epithelial cells
within the terminal duct lobular unit (TDLU), with or without pagetoid extension and …

Update on lobular lesions of the breast

MG Kuba, E Brogi - Histopathology, 2023 - Wiley Online Library
The current histological classification of in‐situ and invasive lobular carcinomas (ILCs)
includes different morphological variants, some of which have been recently described. In …

American registry of pathology expert opinions: the spectrum of lobular carcinoma in situ: diagnostic features and clinical implications

SJ Schnitt, E Brogi, YY Chen, TA King… - Annals of diagnostic …, 2020 - Elsevier
This review reflects a collaboration between the American Registry of Pathology (the
publisher of the Armed Forces Institute of Pathology Fascicles) and Annals of Diagnostic …

Pre-operative management of pleomorphic and florid lobular carcinoma in situ of the breast: report of a large multi-institutional series and review of the literature

MP Foschini, R Miglio, R Fiore, C Baldovini… - European Journal of …, 2019 - Elsevier
Abstract Background Pleomorphic and Florid Lobular carcinoma in situ (P/F LCIS) are rare
variants of LCIS, the exact nature of which is still debated. Aim To collect a large series of …

Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high-risk breast lesion conferences at an academic institution

X Li, Z Ma, TM Styblo, CA Arciero, H Wang… - Breast cancer research …, 2021 - Springer
Background The management of high-risk breast lesions diagnosed on image-guided core
biopsy remains controversial. We implemented a high-risk breast conference attended by …

Atypia in breast pathology: what pathologists need to know

A Katayama, MS Toss, M Parkin, IO Ellis, C Quinn… - Pathology, 2022 - Elsevier
Despite the importance of atypia in diagnosing and classifying breast lesions, the definition
of atypia varies depending on the context, with a lack of consistent and objective criteria for …

[HTML][HTML] High-risk and selected benign breast lesions diagnosed on core needle biopsy: Evidence for and against immediate surgical excision

A Harbhajanka, HL Gilmore, BC Calhoun - Modern Pathology, 2022 - Elsevier
The vast majority of image-detected breast abnormalities are diagnosed by percutaneous
core needle biopsy (CNB) in contemporary practice. For frankly malignant lesions …

The morphologic spectrum of lobular carcinoma in situ (LCIS) observations on clinical significance, management implications and diagnostic pitfalls of classic, florid …

E Brogi - Virchows Archiv, 2022 - Springer
Lobular carcinoma in situ (LCIS) is a non-invasive proliferation of atypical dyscohesive
epithelial cells characterized by loss or functional alteration of E-cadherin-mediated cell …

[HTML][HTML] Morphologic subtypes of lobular carcinoma in situ diagnosed on core needle biopsy: clinicopathologic features and findings at follow-up excision

MG Kuba, MP Murray, K Coffey, C Calle, M Morrow… - Modern Pathology, 2021 - Elsevier
Lobular carcinoma in situ (LCIS) is currently classified as classic (CLCIS), florid (FLCIS), and
pleomorphic (PLCIS). Given the rarity of FLCIS and PLCIS, information on their clinico …